EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13

Carmen Martínez-Fernández iD, Sweta Jha, Elisabet Aliagas, Carina I Holmberg iD, Ernest Nadal iD, Julián Cerón

Cells · 2023

DOI: 10.3390/cells12060929 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Carmen Martínez-Fernández und 5 weiteren Autor:innen. Beteiligte Einrichtung: Modeling Human Diseases in C. elegans Group, Genes, Diseases, and Therapies Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hosp…. Hauptthemen laut MEDLINE: Mesothelioma, Mesothelioma, Malignant, Proteasome Endopeptidase Complex, Ubiquitin Thiolesterase. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Spanish Society of Medical Oncology grant for emerging research groups, Generalitat de Catalunya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The deubiquitinase BAP1 (BRCA1-associated protein 1) is associated with BAP1 tumor predisposition syndrome (TPDS). BAP1 is a tumor suppressor gene whose alterations in cancer are commonly caused by gene mutations leading to protein loss of function. By CRISPR-Cas, we have generated mutations in ubh-4, the BAP1 ortholog in Caenorhabditis elegans, to model the functional impact of BAP1 mutations. We have found that a mimicked BAP1 cancer missense mutation (UBH-4 A87D; BAP1 A95D) resembles the phenotypes of ubh-4 deletion mutants. Despite ubh-4 being ubiquitously expressed, the gene is not essential for viability and its deletion causes only mild phenotypes without affecting 20S proteasome levels. Such viability facilitated an RNAi screen for ubh-4 genetic interactors that identified rpn-9, the ortholog of human PSMD13, a gene encoding subunit of the regulatory particle of the 26S proteasome. ubh-4[A87D], similarly to ubh-4 deletion, cause a synthetic genetic interaction with rpn-9 inactivation affecting body size, lifespan, and the development of germ cells. Finally, we show how ubh-4 inactivation sensitizes animals to the chemotherapeutic agent Bortezomib, which is a proteasome inhibitor. Thus, we have established a model to study BAP1 cancer-related mutations in C. elegans, and our data points toward vulnerabilities that should be studied to explore therapeutic opportunities within the complexity of BAP1 tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MesotheliomaMesothelioma, MalignantProteasome Endopeptidase ComplexUbiquitin ThiolesteraseAnimalsHumansCaenorhabditis elegansDisease Models, AnimalMutationSynthetic Lethal MutationsTumor Suppressor ProteinsCaenorhabditis elegans Proteins

Stichwörter der Autor:innen

BAP1BortezomibC. elegansCRISPR-CasMalignant Pleural MesotheliomaPSMD13proteasomerpn-9ubh-4

Substanzen

Proteasome Endopeptidase ComplexTumor Suppressor ProteinsUbiquitin Thiolesterase26S proteasome non-ATPase regulatory subunit 13BAP1 protein, humanubh-4 protein, C elegansCaenorhabditis elegans Proteins

Autor:innen und Institutionen

  • Modeling Human Diseases in C. elegans Group, Genes, Diseases, and Therapies Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Medicum, Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.
  • Department of Medical Oncology, Institut Català d'Oncologia (ICO), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Preclinical and Experimental Research in Thoracic Tumors (PReTT), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.

ORCID-Profile: Carmen Martínez-Fernández, Carina I Holmberg, Ernest Nadal

Förderung

  • Instituto de Salud Carlos III
  • Spanish Society of Medical Oncology grant for emerging research groups
  • Generalitat de Catalunya
  • European Cooperation in Science and Technology GENiE with a Short Term Mission (STSM)
  • Academy of Finland
  • Magnus Ehrnrooth Foundation

Zitieren

APA

Martínez-Fernández, C., Jha, S., Aliagas, E., Holmberg, C. I., Nadal, E., & Cerón, J. (2023). BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13. Cells. https://doi.org/10.3390/cells12060929

Vancouver

Martínez-Fernández C, Jha S, Aliagas E, Holmberg CI, Nadal E, Cerón J. BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13. Cells. 2023. doi:10.3390/cells12060929

BibTeX
@article{MartnezFernndez2023,
  author = {Martínez-Fernández, Carmen and Jha, Sweta and Aliagas, Elisabet and Holmberg, Carina I and Nadal, Ernest and Cerón, Julián},
  title = {BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4/BAP1 and the Proteasome Subunit rpn-9/PSMD13},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12060929}
}
Kostenlos starten →